Atherosclerosis
Volume 204, Issue 2 , Pages 595-600 , June 2009

Plasma preβ1-HDL level is elevated in unstable angina pectoris

  • Jun Tashiro

      Affiliations

    • Department of Internal Medicine, Matsudo City Hospital, 4005, Kamihongo, Matsudo, Chiba 271-8511, Japan
    • Department of Cardiology, Chiba Cardiovascular Center, 575, Tsurumai, Ichihara, Chiba 290-0512, Japan
    • ,
  • Osamu Miyazaki

      Affiliations

    • Tsukuba Research Institute, Sekisui Medical Co. Ltd. (Daiichi Pure Chemicals Co. Ltd.), 3-3-1, Koyodai, Ryugasaki, Ibaraki 301-0852, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 297 62 6425; fax: +81 297 62 8635.
    • ,
  • Yoshitake Nakamura

      Affiliations

    • Department of Cardiology, Chiba Cardiovascular Center, 575, Tsurumai, Ichihara, Chiba 290-0512, Japan
    • ,
  • Akira Miyazaki

      Affiliations

    • Department of Cardiology, Chiba Cardiovascular Center, 575, Tsurumai, Ichihara, Chiba 290-0512, Japan
    • ,
  • Isamu Fukamachi

      Affiliations

    • Tsukuba Research Institute, Sekisui Medical Co. Ltd. (Daiichi Pure Chemicals Co. Ltd.), 3-3-1, Koyodai, Ryugasaki, Ibaraki 301-0852, Japan
    • ,
  • Hideaki Bujo

      Affiliations

    • Department of Genome Research and Clinical Application, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba 260-8670, Japan
    • ,
  • Yasushi Saito

      Affiliations

    • Department of Clinical Cell Biology, Chiba University Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba 260-8670, Japan

Received 30 June 2008 ,Revised 8 October 2008 ,Accepted 10 October 2008.

References 

  1. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein. Biochemistry. 1988;27:25–29
  2. Barrans A, Jaspard B, Barbaras R, et al. Pre-β HDL: structure and metabolism. Biochim Biophys Acta. 1996;1300:73–85
  3. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res. 1995;36:211–228
  4. Sviridov D, Nestel P. Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis. 2002;161:245–254
  5. Yokoyama S. Apolipoprotein-mediated cellular cholesterol efflux. Biochim Biophys Acta. 1998;1392:1–15
  6. Okuhira K, Tsujita M, Yamauchi Y, et al. Potential involvement of dissociated apoA-1 in the ABCA1-dependent cellular lipid release by HDL. J Lipid Res. 2004;45:645–652
  7. Fitzgerald ML, Morris AL, Chroni A, et al. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res. 2004;45:287–294
  8. Chau P, Nakamura Y, Fielding CJ, et al. Mechanism of prebeta-HDL formation and activation. Biochemistry. 2006;45:3981–3987
  9. Jones LA, Teramoto T, John DJ, et al. Characterization of lipoproteins produced by the perfused rhesus monkey liver. J Lipid Res. 1984;25:319–335
  10. Castle CK, Pape ME, Marotti KR, et al. Secretion of pre-beta-migrating apoA-I by cynomolgus monkey hepatocytes in culture. J Lipid Res. 1991;32:439–447
  11. Rye KA, Clay MA, Barter PJ. Remodeling of high density lipoproteins by plasma factors. Atherosclerosis. 1999;145:227–238
  12. Glomset JA. The lecithin:cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155–167
  13. Francone OL, Gurakar A, Fielding C. Distribution and functions of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in plasma lipoproteins. J Biol Chem. 1989;264:7066–7072
  14. Nakamura Y, Kotite L, Gan Y, et al. Molecular mechanism of reverse cholesterol transport: reaction of pre-β-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. Biochemistry. 2004;43:14811–14820
  15. Miyazaki O, Kobayashi J, Fukamachi I, et al. A new sandwich enzyme immunoassay for measurement of plasma pre-β1-HDL levels. J Lipid Res. 2000;41:2083–2088
  16. Miida T, Nakamura Y, Inano K, et al. Preβ1-high density lipoprotein increases in coronary artery disease. Clin Chem. 1996;42:1992–1995
  17. Asztalos BF, Roheim PS, Milani RL, et al. Distribution of apoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol. 2000;20:2670–2676
  18. Miida T, Miyazaki O, Nakamura Y, et al. Analytical performance of a sandwich enzyme immunoassay for preβ1-HDL in stabilized plasma. J Lipid Res. 2003;44:645–650
  19. Nagasaki T, Akanuma Y. A new colorimetric method for the determination of plasma lecithin–cholesterol acyltransferase activity. Clin Chim Acta. 1977;75:371–375
  20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839–843
  21. Sasahara T, Yamashita T, Sviridov D, et al. Altered properties of high density lipoprotein subfractions in obese subjects. J Lipid Res. 1997;38:600–611
  22. Miida T, Miyazaki O, Hanyu O, et al. LCAT-dependent conversion of preβ1-HDL into α-migrating HDL is severely delayed in hemodialysis patients. J Am Soc Nephrol. 2003;14:732–738
  23. Langmann TJ, Klucken M, Reil G, et al. Molecular cloning of the human ATP-binding cassette transport 1 (hABC1): evidence of sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 1999;257:29–33
  24. Lawn RM, Wade DP, Garbin MR, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999;104:R25–R31
  25. van der Westhuyzen DR, de Beer FC, Webb NR. HDL cholesterol transport during inflammation. Curr Opin Lipidol. 2007;18:147–151
  26. Tiege UJ, Maugeais C, Cain W, et al. Overexpression of secretory phospholipase A(2) causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I. J Biol Chem. 2000;275:10077–10084
  27. Pussinen PJ, Malle E, Metso J, et al. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion. Atherosclerosis. 2001;155:297–305
  28. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis. 1993;102:131–146
  29. Miida T, Yamada T, Yamadera T, et al. Serum amyloid A protein generates preβ1 high-density lipoprotein from α-migrating high density lipoprotein. Biochemistry. 1999;38:16958–16962
  30. Kosuge M, Ebina T, Ishikawa T, et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J. 2007;71:186–190
  31. Meek RL, Urieli-Shoval S, Benditt EP. Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A. 1994;91:3186–3190

PII: S0021-9150(08)00755-7

doi: 10.1016/j.atherosclerosis.2008.10.015

Atherosclerosis
Volume 204, Issue 2 , Pages 595-600 , June 2009

Article Tools

* Image Usage & Resolution